Product Information
NAMZARIC 14 MG-10 MG CAPSULE is a brand product labeled by Allergan, Inc., priced at $19.8476 per EA under NDC 00456121430. Its NADAC has been published 563 times since Dec 23, 2015.
FDA first approved this application on Dec 23, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10; 14 mg/1; mg/1
Manufacturer
Allergan, Inc.NDC
00456121430
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA206439FDA Approved
12/23/2014
TE Code
AB
On Market Since
12/24/2014
Pharmacological Classes
Price Statistics
The NADAC for NAMZARIC 14 MG-10 MG CAPSULE has been published 563 times since Dec 23, 2015, and over the history we have for it it has risen 92.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $19.8476 per EA |
|---|---|
| All-time high | $19.8507 (Aug 12, 2026) |
| All-time low | $10.3076 (Dec 23, 2015) |
| 52-week high | $19.8507 |
| 52-week low | $19.7862 |
| Median price | $16.2942 |
| Average price | $16.0140 |
| Largest weekly change | +9.9% (Jan 13, 2016) |
| Weeks tracked | 563 |
| Tracking since | Dec 23, 2015 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 67% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Allergan, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
memantine hydrochloride and donepezil hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinesterase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NAMZARIC 14 MG-10 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for NAMZARIC 14 MG-10 MG CAPSULE, manufactured by Allergan, Inc., is $19.8476 per EA (NDC 00456121430), effective Sep 30, 2026.
How has the price of NAMZARIC 14 MG-10 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for NAMZARIC 14 MG-10 MG CAPSULE has risen 92.6%. It has been tracked across 563 weekly CMS publications since Dec 23, 2015.
What are the highest and lowest recorded NADAC prices for NAMZARIC 14 MG-10 MG CAPSULE?
Since Dec 23, 2015, the NADAC for NAMZARIC 14 MG-10 MG CAPSULE has ranged from a low of $10.3076 (Dec 23, 2015) to a high of $19.8507 (Aug 12, 2026), with a median of $16.2942 per EA.
Are there cheaper alternatives to NAMZARIC 14 MG-10 MG CAPSULE?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MEMANTINE-DONEPEZIL ER 14-10 MG, is $6.4882 per EA — about 67% below NAMZARIC 14 MG-10 MG CAPSULE.
Who manufactures NAMZARIC 14 MG-10 MG CAPSULE?
NAMZARIC 14 MG-10 MG CAPSULE (NDC 00456121430) is labeled by Allergan, Inc., and CMS classifies it as a brand product.